1Hamamolo Y,Kataoka M, Nogami N, et al. Factors affecting survival time after recurrence of non-small-cell lung cancer treated with concurrent chemoradiotherapy[J]. Jpn J Radiol, 2012,30(3) :249-254.
2Fahel M,Wulff A, Heckel F,et al. Clinical lymph node staging- influence of slice thickness and reconstruction kernel on volumetry and RECIST measurements[J]. Eur J Radiol, 2012, Mar 28.[Epub ahead of print].
3[Epub ahead of print] Terret C, Albrand G, Moncenix G, et al. Karnofsky Performance Scale (KPS) or Physical Performance Test (PPT)? That is the question[J]. Crit Rev Oncol Hematol, 2011,77(2) :142-147.
6Sarah B, Lesley S, Larysa R. Chemotherapy and surgery versus surgery alone in non-small cell lung cancer [ J ]. Cochrane Data- base Syst Rev,2009 ( 1 ) : 1.
7Non-small cell lung cancer collaborative group. Chemotherapy and supportive care versus supportive care alone for advanced non- small cell lung cancer[J]. Cochrane Database Syst Rev, 2011 (2) :31.
8Qingdi Quentin Li,Rebecca X Lee,Liang HS,et al.Enhancement of cisplatin-induced apoptosis by β-elemene in resistant human ovarian cancer cells[J].Med Oncol,2013,30(1):424-444.
9Ye Zhang,Xiao-Dong Mu,En-zhe LI,et al.The role of E3 ubiquitin ligase Cbl proteins in β-elemene reversing multi-drug resistance of human gastric adenocarcinoma cells[J].Int J Mol Sci,2013,14(5):10075-10089.
10Chen Q,Liu S,Chen J,et al.Luteolin induces mitochondria-dependent apoptosis in human lung adenocarcinoma cell[J].Nat Prod Commun,2012,7(1):29-32.
